PCA Investment Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
PCA Investment Advisory Services's BMY Position: Q3 2023 in Review
PCA Investment Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 1,333 shares — an estimated $85.3K sold.
PCA Investment Advisory Services first reported a position in BMY in Q2 2023 and held it in 1 quarter. The position peaked at $85.3K in Q2 2023. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- PCA Investment Advisory Services reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- PCA Investment Advisory Services sold 1,333 Bristol-Myers Squibb shares in Q3 2023, an estimated $85.3K.
- PCA Investment Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 1 quarter.
- PCA Investment Advisory Services's Bristol-Myers Squibb position peaked at $85.3K in Q2 2023.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.